Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Innovative Medical
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
· Male or female \> 18 years of age
* Diagnosis of primary open-angle glaucoma or ocular hypertension
* Untreated IOP \> 18 mm Hg in each eye at the baseline evaluation
* Ability to provide informed consent and likely to complete all study visits
You may not be if
· Known contraindication to bimatoprost, travoprost, timolol, or any component of any study medication
* Uncontrolled systemic disease
* Active ocular disease other than POAG or ocular hypertension
* Required use of ocular medications other than the study medications during the study (intermittent use of OTC artificial tear products will be permitted)
* History of intraocular surgery within the last 3 months
* Patient must not have discontinued use of any medication included in this study in the past for reasons of efficacy or intolerance
Clareo Health | Bimatoprost Monotherapy vs. Dual Therapy With Travoprost and Timolol in Patients With Glaucoma and Ocular Hypertension
